Old Web
English
Sign In
Acemap
>
Paper
>
Leucmie lymphode chronique, alemtuzumab et risque danmie hmolytique
Leucmie lymphode chronique, alemtuzumab et risque danmie hmolytique
2008
A. Laffitte
C.-B. Ghiringhelli
J. Roger-Schmeltz
Emmanuel Damien Riviere
N. Hennequin
N. Lippa
Patrick Mercie
M. Longy-Boursier
Keywords:
Immunology
Medicine
Alemtuzumab
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]